Alphabet’s GOOG stock overtakes Apple in market value — what investors watch next

Alphabet’s GOOG stock overtakes Apple in market value — what investors watch next

NEW YORK, January 7, 2026, 16:28 EST — After-hours

  • Alphabet’s Class C shares rose about 2.5%, putting the company ahead of Apple by market value for the first time since 2019.
  • A fresh price-target hike from Canaccord added fuel as investors leaned back into AI-linked megacaps.
  • Focus now turns to Friday’s U.S. jobs report and Alphabet’s next earnings window in early February.

Alphabet’s non-voting Class C shares climbed on Wednesday, lifting the Google parent above Apple in market value for the first time since 2019. Barrons

The shift matters because it shows where the money is hiding right now: investors are still willing to pay up for companies tied to artificial intelligence, even as the broader tape turns choppy. It also puts Alphabet back in the same conversation as Nvidia at the top end of U.S. equity valuations.

Alphabet’s Class C stock (GOOG) was up about 2.5% at $322.46 after the bell. Apple shares slipped, while Nvidia ended higher. Apnews

Canaccord Genuity analyst Maria Ripps raised her price target — an analyst’s estimate of where a stock could trade — to $390 from $330 and kept a Buy rating. “While they are more cautious in the near-term… they continue to have high conviction on the name longer-term,” the note said, pointing to Gemini’s growth and citing Similarweb data on traffic share. Tipranks

Investors are also still waiting for a clearer read on 2026 spending. Alphabet told analysts on its last earnings call it expected a “significant increase” in capital expenditures this year and would give more detail on the fourth-quarter call. Abc

But the upside case has friction. Courts are weighing how U.S. copyright law applies to generative AI training, with rulings that could reshape costs and business models for companies including Google. Reuters

Near-term, traders are watching Friday’s U.S. nonfarm payrolls report after softer labor readings this week fed a rate-cut debate. Reuters

Beyond that, attention swings to Alphabet’s next results; the company has not confirmed a date, but earnings calendars expect an early-February report. Zacks

Stock Market Today

  • Monte Rosa Therapeutics trades above 12-month target as analysts show mixed paths
    January 8, 2026, 7:16 AM EST. Monte Rosa Therapeutics Inc. (GLUE) traded around $23.23, above the consensus 12-month target of $22.70. The gap spotlights divergent analyst views within Zacks' coverage, where targets range from a low $16.00 to a high $27.50. The average target sits at $22.70, with a standard deviation of about $4.47, underscoring dispersion. Meeting or exceeding a target can prompt downgrades or upward revisions as fundamentals evolve. Current analyst ratings skew toward Strong Buy in the latest estimates, with one Hold and no Sell signals. The article cites Zacks Investment Research via Quandl.com as the data source. Investors must decide whether $22.70 is a waypoint or a stepping stone to higher levels, as current price tests the average target.
Amazon stock rises after Alexa.com CES 2026 debut as AWS self-driving deal grabs attention
Previous Story

Amazon stock rises after Alexa.com CES 2026 debut as AWS self-driving deal grabs attention

Palantir stock (PLTR) ticks up after Truist starts coverage with $223 target, as jobs data looms
Next Story

Palantir stock (PLTR) ticks up after Truist starts coverage with $223 target, as jobs data looms

Go toTop